Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4651439014 | Drospirenone and estetrol only product in oral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4651440011 | Product containing only drospirenone and estetrol in oral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Drospirenone and estetrol only product in oral dose form | Is a | Drospirenone and estetrol only product | true | Inferred relationship | Some | ||
| Drospirenone and estetrol only product in oral dose form | Is a | Drospirenone- and estetrol-containing product in oral dose form | true | Inferred relationship | Some | ||
| Drospirenone and estetrol only product in oral dose form | Has manufactured dose form | Oral dose form | true | Inferred relationship | Some | ||
| Drospirenone and estetrol only product in oral dose form | Has active ingredient | Estetrol (substance) | true | Inferred relationship | Some | 1 | |
| Drospirenone and estetrol only product in oral dose form | Has active ingredient | Drospirenone (substance) | true | Inferred relationship | Some | 2 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely drospirenone 3 milligram and estetrol 14.2 milligram/1 each conventional release oral tablet (clinical drug) | Is a | True | Drospirenone and estetrol only product in oral dose form | Inferred relationship | Some |
This concept is not in any reference sets
FHIR